These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 27644469)

  • 1. Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study.
    Bertelmann T; Feltgen N; Scheffler M; Hufenbach U; Wiedon A; Wilhelm H; Ziemssen F
    Health Qual Life Outcomes; 2016 Sep; 14(1):132. PubMed ID: 27644469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials.
    Ziemssen F; Feltgen N; Holz FG; Guthoff R; Ringwald A; Bertelmann T; Wiedon A; Korb C;
    BMC Ophthalmol; 2017 Jan; 17(1):7. PubMed ID: 28103831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial.
    Mitchell P; Bressler N; Tolley K; Gallagher M; Petrillo J; Ferreira A; Wood R; Bandello F;
    JAMA Ophthalmol; 2013 Oct; 131(10):1339-47. PubMed ID: 23974915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in vision related quality of life in patients with diabetic macular edema: ranibizumab or laser treatment?
    Turkoglu EB; Celık E; Aksoy N; Bursalı O; Ucak T; Alagoz G
    J Diabetes Complications; 2015; 29(4):540-3. PubMed ID: 25817172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion.
    Scott IU; Figueroa MJ; Oden NL; Ip MS; Blodi BA; VanVeldhuisen PC;
    Am J Ophthalmol; 2017 Dec; 184():147-156. PubMed ID: 29074161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials.
    Varma R; Bressler NM; Suñer I; Lee P; Dolan CM; Ward J; Colman S; Rubio RG;
    Ophthalmology; 2012 Oct; 119(10):2108-18. PubMed ID: 22817833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in vision-related function with intravitreal aflibercept: data from phase 3 studies in wet age-related macular degeneration.
    Yuzawa M; Fujita K; Wittrup-Jensen KU; Norenberg C; Zeitz O; Adachi K; Wang EC; Heier J; Kaiser P; Chong V; Korobelnik JF
    Ophthalmology; 2015 Mar; 122(3):571-8. PubMed ID: 25439429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population.
    Jelin E; Wisløff T; Moe MC; Heiberg T
    Health Qual Life Outcomes; 2019 Aug; 17(1):140. PubMed ID: 31412873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Design of the ORCA module in the OCEAN study : Evaluation of SD-OCT results in daily routine practice].
    Heimes B; Schick T; Brinkmann CK; Wiedon A; Haegele B; Kirchhof B; Holz FG; Pauleikhoff D; Ziemssen F; Liakopoulos S; Spital G; Schmitz-Valckenberg S
    Ophthalmologe; 2016 Jul; 113(7):570-80. PubMed ID: 26868827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-site Baseline and Short-term Outcomes of Clinical Characteristics and Life Quality Evaluation of Chinese Wet Age-related Macular Degeneration Patients in Routine Clinical Practice.
    Wang LL; Liu WJ; Liu HY; Xu X
    Chin Med J (Engl); 2015 May; 128(9):1154-9. PubMed ID: 25947396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vision-related function after ranibizumab treatment for diabetic macular edema: results from RIDE and RISE.
    Bressler NM; Varma R; Suñer IJ; Dolan CM; Ward J; Ehrlich JS; Colman S; Turpcu A;
    Ophthalmology; 2014 Dec; 121(12):2461-72. PubMed ID: 25148789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving in Patients With Diabetic Macular Edema: Report From RESTORE, RIDE, and RISE Trials.
    Bressler NM; Varma R; Mitchell P; Suñer IJ; Dolan C; Ward J; Ferreira A; Ehrlich JS; Turpcu A
    JAMA Ophthalmol; 2016 Feb; 134(2):160-6. PubMed ID: 26584450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials.
    Suñer IJ; Kokame GT; Yu E; Ward J; Dolan C; Bressler NM
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3629-35. PubMed ID: 19255158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration.
    Zhu M; Wijeyakumar W; Syed AR; Joachim N; Hong T; Broadhead GK; Li H; Luo K; Chang A
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):475-484. PubMed ID: 27572301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of initial visual acuity on anti-VEGF treatment outcomes in patients with macular oedema secondary to retinal vein occlusions in routine clinical practice.
    Wai KM; Khan M; Srivastava S; Rachitskaya A; Silva FQ; Deasy R; Schachat AP; Babiuch A; Ehlers JP; Kaiser PK; Yuan A; Singh RP
    Br J Ophthalmol; 2017 May; 101(5):574-579. PubMed ID: 27503394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast sensitivity and quality of life following intravitreal ranibizumab injection for central retinal vein occlusion.
    Murakami T; Okamoto F; Sugiura Y; Morikawa S; Okamoto Y; Hiraoka T; Oshika T
    Br J Ophthalmol; 2023 Feb; 107(2):254-260. PubMed ID: 34452939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between improvement in visual acuity and QOL after Ranibizumab treatment for age-related macular degeneration patients: QUATRO study.
    Oshima Y; Ishibashi Y; Umeda N; Nagata T; Yoshida S; Uchio E; Kondo H; Sonoda KH; Ishibashi T
    BMC Ophthalmol; 2021 Jan; 21(1):58. PubMed ID: 33485320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy/safety of ranibizumab monotherapy or with laser versus laser monotherapy in DME.
    Berger A; Sheidow T; Cruess AF; Arbour JD; Courseau AS; de Takacsy F
    Can J Ophthalmol; 2015 Jun; 50(3):209-16. PubMed ID: 26040221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
    Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
    Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Ranibizumab Loading Treatment on Vision-Related Quality of Life in Diabetic Macular Edema.
    Daldal H; Turkyilmaz M; Balikoglu Yilmaz M; Berberoglu U
    Clin Pract; 2021 Sep; 11(3):659-670. PubMed ID: 34563010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.